Your Article Summary
See Latest ArticlesThe Importance of Integrated Risk Management When Treating Patients with Hypertension: Benefits of Angiotensin II Receptor Antagonist Therapy
Clinical and Experimental Hypertension, 07/23/08
Ruilope LM et al. - Angiotensin II receptor blockers (ARBs) are highly efficacious, persistent, well-tolerated antihypertensive agents, with additional benefits in comorbid hypertension, CV pathologies, end-organ damage, and, in diabetes, diabetic nephropathy or metabolic syndrome. ARBs decrease overall risk of CV and end-organ disease, CVD-related mortality, and cerebrovascular events in patients with hypertension.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Rifaximin in the management of colonic diverticular disease
Expert Review of Gastroenterology & Hepatology, 12/06/09
Divalproex Sodium-Induced Eosinophilic Pleural Effusion
American Journal of Therapeutics, 12/04/09
Lithium and thyroid
Best Practice & Research Clinical Endocrinology & Metabolism, 12/04/09
Today in Vascular Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Liquid versus foam sclerotherapy
Phlebology, 12/04/09
Foam sclerotherapy: cardiac and cerebral monitoring
Phlebology, 12/04/09
Is Moderate Atherosclerotic Stenosis in the Middle Cerebral Artery a Cause of or a Coincidental Finding in Ischemic Stroke
Cerebrovascular Diseases, 12/04/09